NanoViricides Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for NanoViricides.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for NanoViricides.

Recommendation Trends

Rating	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	1	1	2	2	2
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tim Moore EF Hutton	EF Hutton	Strong Buy Reiterates $6.5	Strong Buy	Reiterates	$6.5	+428.46%	May 7, 2024
Tim Moore EF Hutton	EF Hutton	Strong Buy Reiterates $6.5	Strong Buy	Reiterates	$6.5	+428.46%	Feb 16, 2024
Constantine Davides EF Hutton	EF Hutton	Strong Buy Initiates $5.25	Strong Buy	Initiates	$5.25	+326.83%	Jun 1, 2023
Constantine Davides EF Hutton	EF Hutton	Strong Buy Reiterates $5.25	Strong Buy	Reiterates	$5.25	+326.83%	Apr 18, 2023
Constantine Davides EF Hutton	EF Hutton	Strong Buy Maintains $8.5 → $5.25	Strong Buy	Maintains	$8.5 → $5.25	+326.83%	Feb 28, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.59

from -0.63

EPS Next Year

-0.47

from -0.59

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.81	-0.70	-0.74	-0.70	-0.63	-0.59	-0.47
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.61	-0.48
Avg	-0.59	-0.47
Low	-0.57	-0.45

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.